4 employees
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
2017
$1.7M
from 2 investors over 2 rounds
Eclipse Regenesis raised $1.7M on August 26, 2021
Investors: National Institutes of Health
Eclipse Regenesis raised $256K on April 2, 2021
Investors: National Science Foundation SBIR/STTR